Skip to main content

Advertisement

Table 5 Univariate analysis of risk factors for CMV IgM positive in patients with inflammatory bowel disease

From: The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China

  CMV IgM+/IgM-
  UC CD
  (3/186) (1/36)
Age Number P value OR (95% CI) Number P value OR (95% CI)
 ≤50 ys 2/137 1.000 0.715 (0.063 ~ 8.065) 1/23 1.000 N/A
 >50 ys 1/49    0/13   
Sex       
 male 2/107 1.000 1.477 (0.132 ~ 16.573) 1/22 1.000 N/A
 female 1/79    0/14   
Smoking       
 yes 1/44 1.000 1.614 (0.143 ~ 18.222) 1/8 0.243 N/A
 no 2/142    0/28   
Drinking       
 yes 1/74 1.000 0.757 (0.067 ~ 8.496) 0/12 1.000 N/A
 no 2/112    1/24   
Diet composition       
 vegetarian food 0/18 1.000 N/A 0/6 1.000 N/A
 mixed food 3/168    1/30   
Fever       
 yes 1/31 1.000 2.500 (0.220 ~ 28.432) 0/4 1.000 N/A
 no 2/155    1/32   
Hemoglobin (G/L)       
 ≤70 1/8 0.329 11.125 (0.911 ~ 135.909) 0/0 - N/A
 >70 2/178    1/36   
Albumin (G/L)       
 ≤35 2/19 0.031* 17.579 (1.522 ~ 203.083) 1/12 0.351 N/A
 >35 1/167    0/24   
Disease severity       
 mild and moderate 1/167 0.031* 0.057 (0.005 ~ 0.657) 1/29 1.000 N/A
 severe 2/19    0/7   
Location       
 distal colitis 1/139 0.337 0.169 (0.015 ~ 1.907)    
 pancolitis 2/47      
 ileal     1/7 0.155 N/A
 Colonic     0/14   
 ileocolon     0/15   
Treatment       
ASA/SASP 3/146 1.000 N/A 1/19 1.000 N/A
corticosteroids 3/44 0.015* N/A 0/8 1.000 N/A
immunosuppressant 3/2 <0.001* N/A 0/2 1.000 N/A
  1. CMV, cytomegalovirus; UC, ulcerative colitis; CD, Crohn’s disease; OR, Odds ratio; CI, confidence interval; ASA, aminosalicylic acid; SASP, salicylazosulfapyridine.
  2. *indicate significant difference.